The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of COVID-19 pandemic on the treatment of prostate cancer in Brazilian public health system, comparing pre and post pandemic data.
 
Gustavo Carvalhal
No Relationships to Disclose
 
Guilherme Zulli
No Relationships to Disclose
 
Igor Alexandre Morbeck
No Relationships to Disclose
 
Daniel Herchenhorn
Consulting or Advisory Role - Adium Pharma; Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology
 
Andre Sasse
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; Merck KGaA; MSD Oncology
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; MSD Oncology; Pfizer
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)
 
Brent Rose
Employment - UC San Diego Health
 
Fernando Maluf
Honoraria - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; Ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp & Dohme
 
Fernando Monteiro
Speakers' Bureau - Adium Pharma; BMS Brazil; MSD Oncology
Travel, Accommodations, Expenses - Adium Pharma; Ipsen; Merck Serono; MSD Oncology
Other Relationship - Brazilian Information in Oncology - BIO
 
Vinicius Souza
No Relationships to Disclose
 
Andrey Soares
Honoraria - Adium Pharma; Astellas Pharma; AstraZeneca; Bayer; BMS Brazil; Janssen; Merck Serono; MSD; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Adium Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Adium Pharma; Bayer; Ipsen; Janssen; Merck Serono; MSD
 
Denis Jardim
No Relationships to Disclose
 
Diogo Bastos
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; MSD
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; MSD Oncology; MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag
 
Dr. Paulo Lages
Honoraria - Astellas Medivation; Bayer; BMS Brazil; Ipsen; Janssen Oncology; MSD Oncology
Consulting or Advisory Role - Astellas Medivation; Bayer; Janssen Oncology; Novartis
Speakers' Bureau - Astellas Medivation; Bayer; Janssen Oncology; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology
 
Elcio Firminiano
No Relationships to Disclose
 
Douglas Valverde
Employment - Techtrials
Leadership - Techtrials
 
Nicholas James
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; EUSA pharma; Janssen; pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Ferring; Janssen Oncology; Merck; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi